AI-Driven Pharma Market Research: Synthetic Users – with Kwame Ferreira & Rebecca Gould
Welcome back to the IDEA Collider podcast. In this episode, host Rick Ritacco sits down with Kwame Ferreira, Founder of
Fulcrum Research Division
The Modern Patient Experience
How AI and expanded stakeholder perspectives are transforming rare disease patient journey research. Download the report to learn:
Why the ATU needs to evolve with the brand
Steve Wakefield leads the Quantitative Center of Excellence at Fulcrum Research, part of SAI. With more than 25 years of
Stability and Flexibility: Transforming your ATU tracker into an adaptive learning system
Your market changes – your ATU should change, too At Fulcrum Research, we transform your ATU into an adaptive learning
Closing the AI Perception Gap
A perspective from Fulcrum Research Group A recent article from bi.team explored an idea that immediately resonated with us: people tend to believe AI
Why Patient Journey Research Shouldn’t End with a PowerPoint
Every pharmaceutical company conducts research to better understand patients. Then, more often than not, those insights live on a shared
How I Learned to Love My ATU
Our Best Practices for Tracking Research. Tracking research is a foundational part of any market research plan. Studies under the
Accurate Product Forecasting
An accurate prediction of future market share can help optimize strategy beyond sales and marketing, impacting decisions as far-reaching as
Choose Your Own Adventure
A unique Market Research approach to inform rare disease education. The Challenge. One of the common challenges orphan drug makers
Using Archetypes to Understand Prescribing Decisions
Healthcare marketing now recognizes that prescribing decisions—like all decisions—are never purely rational. But the search to identify heuristics and other